A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration

被引：0
|
作者：
de Motta, Laura Lores [1 ]
Van Asten, Freekje [1 ]
Muether, Philipp S. [2 ]
Smailhodzic, Dzenita [1 ]
Chen, John C. [3 ]
Koenekoop, Robert K. [3 ,4 ,5 ]
Fauser, Sascha [2 ]
Hoyng, Carel C. B. [1 ]
Den Hollander, Anneke I. [1 ,6 ]
de Jong, Eiko [1 ]
机构：
[1] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands
[2] Univ Hosp Cologne, Dept Ophthalmol, Cologne, Germany
[3] McGill Univ, Dept Ophthalmol, Ctr Hlth, Montreal, PQ H3A 2T5, Canada
[4] McGill Univ, Dept Pediat Surg, Ctr Hlth, Montreal, PQ, Canada
[5] McGill Univ, Dept Human Genet, Ctr Hlth, Montreal, PQ, Canada
[6] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2015年 / 56卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3990
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Adherence to ranibizumab treatment for neovascular age-related macular degeneration in real life
    Droege, Katharina M.
    Muether, Philipp S.
    Hermann, Manuel M.
    Caramoy, Albert
    Viebahn, Ulrike
    Kirchhof, Bernd
    Fauser, Sascha
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 251 (05) : 1281 - 1284
  • [22] Factors Associated With the Response of Age-Related Macular Degeneration to Intravitreal Ranibizumab Treatment
    Yamashiro, Kenji
    Tomita, Kaoruko
    Tsujikawa, Akitaka
    Nakata, Isao
    Akagi-Kurashige, Yumiko
    Miyake, Masahiro
    Ooto, Sotaro
    Tamura, Hiroshi
    Yoshimura, Nagahisa
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2012, 154 (01) : 125 - 136
  • [23] Implementation studies of ranibizumab for neovascular age-related macular degeneration
    Bloch, Sara Brandi
    ACTA OPHTHALMOLOGICA, 2014, 92 (01) : 98 - 98
  • [24] Adherence to ranibizumab treatment for neovascular age-related macular degeneration in real life
    Katharina M. Droege
    Philipp S. Muether
    Manuel M. Hermann
    Albert Caramoy
    Ulrike Viebahn
    Bernd Kirchhof
    Sascha Fauser
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2013, 251 : 1281 - 1284
  • [25] Ranibizumab: A Review of Its Use in the Treatment of Neovascular Age-Related Macular Degeneration
    Frampton, James E.
    DRUGS & AGING, 2013, 30 (05) : 331 - 358
  • [26] Switching between ranibizumab and aflibercept for the treatment of neovascular age-related macular degeneration
    Mantel, Irmela
    Gillies, Mark C.
    Souied, Eric H.
    SURVEY OF OPHTHALMOLOGY, 2018, 63 (05) : 638 - 645
  • [27] Review of Ranibizumab Trials for Neovascular Age-Related Macular Degeneration
    Patel, Ravi D.
    Momi, Rominder S.
    Hariprasad, Seenu M.
    SEMINARS IN OPHTHALMOLOGY, 2011, 26 (06) : 372 - 379
  • [28] Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration.
    Folk, James C.
    Stone, Edwin M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (17): : 1648 - 1655
  • [29] Implementation studies of ranibizumab for neovascular age-related macular degeneration
    Bloch, Sara Brandi
    ACTA OPHTHALMOLOGICA, 2013, 91 : 1 - 22
  • [30] Therapeutic effects of ranibizumab in neovascular age-related macular degeneration
    Ciulla, Thomas A.
    EXPERT REVIEW OF OPHTHALMOLOGY, 2007, 2 (05) : 679 - 693
12345